- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06190795
A Smartphone Application for a Self-directed Upper Limb Therapy After Stroke
Feasibility and Effectiveness of AI-powered Interactive Smartphone Application for a Self-directed Upper Limb Therapy Implementation After Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background To intensify practice to influence neuroplasticity to optimize UL recovery after stroke, it is important to empower people with stroke to perform self-directed UL therapy outside therapy. However, it has been found that increasing UL practice is often challenging with high level of inactivity found in people with stroke during rehabilitation. Traditionally, self-directed program has been delivered via hard copy manuals. Hardcopy manuals are often cumbersome and difficult to retrieve and handle, especially for those with moderate/severe UL impairment. Hence a more accessible format of exercise/activities instructions is needed. There is lack of reminders for people with stroke to keep up to prescribed exercise regime. This may affect adherence as some may not remember the prescribed practice sessions. Without immediate feedback of UL movement performed during self-practice, people with stroke may continue with compensatory movement performance without correction. This may in turns hinder UL recovery.
The aim of this study is to overcome these challenges by developing an AI-powered interactive smartphone application called AMPLIFY app that enables prescription and progression of exercises/functional activities, while offering immediate feedback on UL movement performed, real-time logging and monitoring of adherence through virtual platform. The inherent interactive nature of app offers features to engage and remind people with stroke to use their paretic UL. This app offers remote monitoring and supervision by therapists without need for actual therapists' physical presence. As the AMPLIFY app is a newly developed AI-powered interactive smartphone application, it is important to investigate the app's feasibility, usefulness in improving users' experience, effect on adherence, UL use, recovery and cost-effectiveness.
Aim:
To Investigate:
- Feasibility of AMPLIFY app in completing self-directed UL therapy programme
- Usefulness of AMPLIFY app in improving the users' experience in self-directed UL therapy programme performance
- Effectiveness of AMPLIFY app in increasing adherence in self-directed UL therapy programme performance
- Effectiveness of AMPLIFY app in increasing UL use, confidence and improving recovery after stroke
- Cost-effectiveness of AMPLIFY app in reducing the need for clinical review in self-directed UL therapy programme performance
Methods:
The study is a prospective randomized controlled trial (RCT) to compare the implementation of AMPLIFY programme in two modes of delivery- smartphone app versus hardcopy manuals to investigate the aims mentioned above.
People with stroke who fit into the inclusion and exclusion criteria will be invited to participate in the study via informed consent by the research assistant (RA)/ study team members. Once the informed consent has been given by the participants, the participants will undergo the pre-intervention assessment. After the pre-intervention assessment, the participants will be randomised either to the experimental group (AMPLIFY programme via the smartphone app) or control group (AMPLIFY programme via the hardcopy manuals). The intervention of experimental and control arms are described below. Both groups essentially undergo the same AMPLIFY programme but via different modes. Time points of assessment: pre-intervention, post-intervention and post-3months intervention assessments.
Experimental arm Assigned intervention The AMPLIFY Programme will be delivered via smartphone application with two levels. Level 1 is catered for people with stroke with Action Research Arm Test (ARAT) score <34, while Level 2 is catered for people with stroke with ARAT score >=34. Level 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Level 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the experimental group will be as follows: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).
Control arm Assigned intervention The AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2). Booklet 1 is catered for people with stroke with ARAT score <34, while Booklet 2 is catered for people with stroke with ARAT score >=34. Booklet 1 consists of six warm up exercises, six strengthening exercises and ten functional activities. Booklet 2 consists of three warm up exercises, four strengthening exercises, nine hand coordination and dexterity exercises, and ten functional activities. Five to six exercises (including at least one functional activity) will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver. Stroke participants are to performed the exercises/functional activities three sessions per day (i.e. morning, afternoon, evening) and for six days per week. In addition, the stroke participants are to use their paretic UL to perform the functional activities prescribed to them whenever needed throughout the day. The AMPLIFY programme will last for four weeks. If the stroke participants are discharged before the AMPLIFY programme ends, the participants will continue with the programme at home with the reviews being performed by the therapists via tele-rehabilitation. Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Singapore
-
Singapore, Singapore, Singapore, 307382
- Lay Fong Chin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of stroke (confirmed by CT/MRI scans)
- ≤four weeks post-stroke
- Montreal Cognitive Assessment (MOCA)>=21
- Finger extension Medical Research Council (MRC) >=1
- Fugl Meyer Upper Limb score <60 or NIHSS Motor Arm section score>=2
- Potential discharge to home (able to do tele-rehabilitation for review)
Exclusion Criteria:
- Bilateral stroke
- Montreal Cognitive Assessment (MOCA)<21
- Paretic upper limb numeric pain rating scale (NPRS)>5
- Reduced paretic upper limb use prior to stroke episode (e.g. frozen shoulder, fracture, etc)
- Reduced paretic upper limb use due to orthopaedic problems such as fracture in existing stroke episode
- Medically unstable
- Neglect as ascertained by treatment team
- Severe behavioural disturbance or agitation or epilepsy or untreated depression or psychiatric conditions
- Pregnancy or lactation states
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Smartphone Application
AMPLIFY Programme delivered via smartphone application with 2 levels.
Level 1 is catered for people with stroke with ARAT score <34, while Level 2 is catered for people with stroke with ARAT score >=34.
Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver.
Stroke participants are to performed exercises 3 sessions per day for 6 days per week.
Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day.
AMPLIFY programme will last for 4 weeks.
If the stroke participants are discharged before 4 weeks, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation.
Frequency of reviews for the experimental group will be: Week1 (2x); Week2 (1x); Week3 (x0); Week4 (x1).
|
AMPLIFY Smartphone Application enables prescription and progression of exercises/functional activities, while offering immediate feedback on upper limb movement performed, real-time logging and monitoring of adherence through virtual platform
|
|
Active Comparator: Hardcopy Manual
AMPLIFY Programme will be delivered via hardcopy manual.
AMPLIFY Programme consists of two booklets (Booklet 1 and Booklet 2).
Booklet 1 is catered for people with stroke with ARAT score <34, while Booklet 2 is catered for people with stroke with ARAT score >=34.
Five to 6 exercises will be prescribed to the stroke participants for each session to be performed independently or with the help of caregiver.
Stroke participants are to performed the exercises 3 sessions per day for 6 days per week.
Stroke participants are to use paretic UL to perform functional activities prescribed whenever needed throughout the day.
AMPLIFY programme will last for 4 weeks.
If stroke participants are discharged before AMPLIFY programme ends, the participants will continue at home with the reviews being performed by the therapists via tele-rehabilitation.
Frequency of reviews for the control group will be as follows: Week1 (3x); Week2 (2x); Week3 (x1); Week4 (x1).
|
Hardcopy Manual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Action Research Arm Test
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)
|
Change from pre-intervention to immediate post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility - Number of drop-out
Time Frame: Throughout the 4 weeks of intervention
|
Number of drop-out from AMPLIFY Programme
|
Throughout the 4 weeks of intervention
|
|
Feasibility- Number of adverse events related to AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
|
Number of adverse events related to intervention
|
Throughout the 4 weeks of intervention
|
|
AMPLIFY Programme Adherence
Time Frame: Throughout the 4 weeks of intervention
|
Percentage of adherence to the prescribed AMPLIFY Programme
|
Throughout the 4 weeks of intervention
|
|
Number of upper limb repetitions performed in AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
|
Number of upper limb repetitions performed in AMPLIFY Programme
|
Throughout the 4 weeks of intervention
|
|
Number of Clinical Reviews in AMPLIFY Programme
Time Frame: Throughout the 4 weeks of intervention
|
Number of Clinical Reviews in AMPLIFY Programme
|
Throughout the 4 weeks of intervention
|
|
Change in Action Research Arm Test
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in Action Research Arm Test (minimum score 0 - maximum score 57; the higher the score the better the upper limb performance)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
Change in Upper Limb Self-Efficacy Test
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)
|
Change from pre-intervention to immediate post-intervention
|
|
Change in Upper Limb Self-Efficacy Test
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in Upper Limb Self-Efficacy Test (minimum score 0 - maximum score 200; the higher the score the higher the level of self-efficacy in upper limb use)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
Change in Rating of Everyday Arm-use in the Community and Home
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)
|
Change from pre-intervention to immediate post-intervention
|
|
Change in Rating of Everyday Arm-use in the Community and Home
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in Rating of Everyday Arm-use in the Community and Home (minimum score 0 -maximum score 5; the higher the score the higher the level of upper limb use)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
Change in Stroke Rehabilitation Motivation Scale
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)
|
Change from pre-intervention to immediate post-intervention
|
|
Change in Stroke Rehabilitation Motivation Scale (SRMS)
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in Stroke Rehabilitation Motivation Scale (minimum score 28 - maximum score 140; the higher the score the higher the level of motivation)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
Change in upper limb pain visual analogue scale
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)
|
Change from pre-intervention to immediate post-intervention
|
|
Change in upper limb pain visual analogue scale
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in upper limb pain visual analogue scale (minimum score 0 - maximum score 10; the higher the score the higher the level of upper limb pain)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
Change in upper limb Modified Ashworth Scale
Time Frame: Change from pre-intervention to immediate post-intervention
|
Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)
|
Change from pre-intervention to immediate post-intervention
|
|
Change in upper limb Modified Ashworth Scale
Time Frame: Change from immediate post-intervention to 3 month post-intervention
|
Change in upper limb Modified Ashworth Scale (minimum score 0 - maximum score 4; the higher the score the higher the level of upper limb resistance to passive movement)
|
Change from immediate post-intervention to 3 month post-intervention
|
|
User Experience Survey
Time Frame: End of 4 weeks intervention
|
Feedback on user experience on hardcopy manual / smartphone application (minimum score 0 - maximum score 40; the higher the score the higher the ease and satisfaction to the use of the hardcopy manual / smartphone application)
|
End of 4 weeks intervention
|
|
Affinity for Technology Interaction Scale
Time Frame: Pre-intervention
|
Affinity for Technology Interaction Scale (minimum score 1 - maximum score 6; the higher the score the higher the affinity to technology)
|
Pre-intervention
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/00507
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on AMPLIFY Smartphone Application
-
Jordan University of Science and TechnologyCompletedUrinary IncontinenceJordan
-
Kibi International UniversityCompleted
-
University Hospital, MontpellierCompleted
-
Gunma UniversityCompletedSubthreshold DepressionJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMalignant Solid Neoplasm | Sarcoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Central Nervous System NeoplasmUnited States
-
Recovery Record ResearchStanford UniversityCompletedBulimia Nervosa | Eating Disorders | Binge Eating DisorderUnited States
-
University Hospital, BrestUnknownPhysical Activity | Pregnant | Mobile Health AppsFrance
-
University of PittsburghTuscarora Intermediate Unit 11Recruiting
-
University Hospital, GrenobleRecruitingRaynaud PhenomenonFrance
-
Jordan University of Science and TechnologyActive, not recruitingPostpartum Depression | Postpartum Depression (PPD)Jordan